The effect of monoamine oxidase inhibitors on some arylalkylamines in rate striatum.
D000588:Amines / Q000378:metabolism*; D000818:Animals; D003010:Clorgyline / Q000494:pharmacology; D003342:Corpus Striatum / Q000187:drug effects / Q000378:metabolism*; D007490:Iproniazid / Q000494:pharmacology; D008297:Male; D008995:Monoamine Oxidase / Q000378:metabolism; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology*; D010293:Pargyline / Q000494:pharmacology; D010627:Phenethylamines / Q000378:metabolism; D051381:Rats; D012642:Selegiline / Q000494:pharmacology; D014191:Tranylcypromine / Q000494:pharmacology; D014363:Tryptamines / Q000378:metabolism; D014439:Tyramine / Q000378:metabolism
D000588:Amines; D008996:Monoamine Oxidase Inhibitors; D010627:Phenethylamines; D014363:Tryptamines; D012642:Selegiline; D014191:Tranylcypromine; D010293:Pargyline; D007490:Iproniazid; D008995:Monoamine Oxidase; D003010:Clorgyline; D014439:Tyramine